Differences in growth signaling pathway activation in small cell and non-small cell carcinomas of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 326s Year: 2006
Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016 Year: 2017
Magnolol can induce apoptosis in non-small cell lung cancer via caspase-independent pathway Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Bile acid receptor mediates cancer-associated fibroblasts-induced migration and invasion of non-small cell lung cancer cells Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002
CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019
Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
Toll-like receptor 3 is up-regulated and enhances anti-proliferative function in human non-small cell lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008
GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1 Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017
The death receptor Fas in CD3+T cells in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 673s Year: 2004
Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
Involvement of Fas/FasL system in gemcitabine-induced lung cancer cell killing Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018
The expression of central cell cycle regulators in non-small cell lung cancer has therapy-dependent prognostic impact Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012